Bhowmick Neil
SEC CIK 1872210 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KAPA | Kairos Pharma, LTD. | CSO | 1.31M | — | — | 2 | 2025-01-01 | 2025-10-08 |
Most active insiders at KAPA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Samuelson Doug | CFO | — | — |
| 2 | Bhowmick Neil | CSO | — | — |
| 3 | Murali Ramachandran | VP of Research, Development | — | — |
| 4 | Yu John S | CEO, COB, Dir, 10% | — | — |
| 5 | Singhvi Rahul | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-30 | 2025-10-08 | KAPA | Kairos Pharma, LTD. | Bhowmick Neil | CSO | A - Grant | $0.00 | +171.8K | 1.31M | +15% | $0 | |
| 2025-04-07 | 2025-01-01 | KAPA | Kairos Pharma, LTD. | Bhowmick Neil | CSO | A - Grant | $0.00 | +14.0K | 1.14M | +1% | $0 |
Purchase Sale Sale after option exercise All abbreviations